SANDRENA estradiol 0.1% gel 1g sachets Australia - English - Department of Health (Therapeutic Goods Administration)

sandrena estradiol 0.1% gel 1g sachets

orion pharma (aus) pty limited - estradiol, quantity: 1 mg/g - gel - excipient ingredients: purified water; propylene glycol; carbomer 934p; ethanol; trolamine - short-term treatment of climacteric symptoms after natural or surgical menopause. whenever possible the lowest effective dose should be used. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, see section 5.1 pharmacodynamic properties - clinical trials and section 4.4 special warnings and precautions for use). sandrena should only be continued for as long as the benefit outweighs the risks

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel tube

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel bottle Australia - English - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel bottle

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

ORAQIX Periodontal Gel lidocaine (lignocaine) 25 mg/g and prilocaine 25 mg/g Australia - English - Department of Health (Therapeutic Goods Administration)

oraqix periodontal gel lidocaine (lignocaine) 25 mg/g and prilocaine 25 mg/g

dentsply sirona pty ltd - prilocaine, quantity: 42.5 mg; lidocaine, quantity: 42.5 mg - gel - excipient ingredients: poloxamer; hydrochloric acid; purified water - for use in adults for localised anaesthesia in periodontal pockets for probing, scaling and/or root planing.

ZINDACLIN clindamycin (as clindamycin phosphate) 1% topical gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

zindaclin clindamycin (as clindamycin phosphate) 1% topical gel tube

medis pharma pty ltd - clindamycin phosphate, quantity: 1.188 % w/w - gel - excipient ingredients: propylene glycol; sodium hydroxide; purified water; hyetellose; ethanol; zinc acetate - zindaclin is indicated for the treatment of acne vulgaris, particularly forms in which comedones, papules and pustules predominate.

SOLARAZE diclofenac sodium 3 % gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

solaraze diclofenac sodium 3 % gel tube

mayne pharma international pty ltd - diclofenac sodium, quantity: 3 % w/w - gel - excipient ingredients: polyethylene glycol monomethyl ether; benzyl alcohol; sodium hyaluronate; purified water - management of actinic keratosis.

ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube Australia - English - Department of Health (Therapeutic Goods Administration)

acnatac clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube

viatris pty ltd - tretinoin, quantity: 0.25 mg; clindamycin phosphate, quantity: 12 mg (equivalent: clindamycin, qty 10 mg) - gel - excipient ingredients: purified water; disodium edetate; methyl hydroxybenzoate; carbomer 981; butylated hydroxytoluene; polysorbate 80; citric acid; glycerol; propyl hydroxybenzoate; trometamol - acnatac is indicated for the topical treatment of acne vulgaris when comedones, papules and pustules are present in patients 12 years or older. consideration should be given to official guidance on the appropriate use of antibacterial agents and acne treatment.

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

mirvaso brimonidine 3.3 mg/g (as tartrate) gel tube

galderma australia pty ltd - brimonidine tartrate, quantity: 5 mg/g (equivalent: brimonidine, qty 3.3 mg/g) - gel - excipient ingredients: carbomer 974p; methyl hydroxybenzoate; phenoxyethanol; glycerol; titanium dioxide; propylene glycol; sodium hydroxide; purified water - mirvaso is indicated for the treatment of facial erythema of rosacea in adult patients

DUAC ONCE DAILY GEL clindamycin (as phosphate ) 1% and benzoyl peroxide 5% topical gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

duac once daily gel clindamycin (as phosphate ) 1% and benzoyl peroxide 5% topical gel tube

glaxosmithkline australia pty ltd - benzoyl peroxide, quantity: 50 mg/g; clindamycin phosphate, quantity: 11.9 mg/g (equivalent: clindamycin, qty 10 mg/g) - gel - excipient ingredients: silicon dioxide; purified water; glycerol; sodium hydroxide; disodium lauril sulfosuccinate; dimeticone 100; carbomer 980; poloxamer; disodium edetate - for the topical treatment of comedo, papules and pustular acne vulgaris.

CRINONE 8% progesterone 90mg/1.125g gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

crinone 8% progesterone 90mg/1.125g gel tube

merck healthcare pty ltd - progesterone, quantity: 90 mg - gel - excipient ingredients: purified water; polycarbophil; carbomer 934p; sodium hydroxide; sorbic acid; light liquid paraffin; hydrogenated palm glycerides; glycerol - for ivf and (art) where luteal phase support is indicated.